CBD Infused Beverages Market Size Expected to Reach USD 2.8 Billion by 2025
I
n the past, THC and CBD were (and still are) battling it out for what segment is achieving the higher percentage and the total amount of revenues generated... but when it comes to the beverages market... there seems to be green fields aplenty for them both!
A recent report by Grand View Research said that the global cannabis beverages market size is expected to reach USD 2.8 Billion by 2025 at a CAGR of 17.8%. The report looked at alcoholic and non-alcoholic beverages using either TCH or CBD. It said By component, the market is segmented into Cannabidiol (CBD) and Tetrahydrocannabinol (THC).
The demand of THC infused cannabis beverages is majorly driven by rising product demand from adult consumers for recreational purposes. Rising demand for the therapeutic effects of the component along with the euphoria it provides is expected to bode well for the growth of the segment in the forthcoming years.
Active companies in the industry making moves to ready that include Cannabis Global, Inc. (OTCPK MCTC), Aphria Inc. (NYSE APHA) (TSXAPHA), CV Sciences, Inc. (OTCQB CVSI), Hexo Corp (NYSE HEXO) (TSXHEXO), Molson Coors Beverage Co. (NYSE TAP).
While on the other hand, it explained CBD infused cannabis drinks are registered the fastest growth in (prior years). Also, the demand is expected to witness a surge over the forecasted period owing to the non-psychoactive properties of CBD. Lack of psychoactive effect in the CBD drinks is widening its scope for usage of the drinks in medical purposes. Many consumers are considering CBD drinks as a wellness and anti-inflammatory products, such as kombucha-a probiotic drink. This drink can potentially be used for treating chronic pain, anxiety, substance use disorders and central nervous system diseases. These factors are expected to boost the adoption of the product, resulting in the growth of the segment.
Cannabis Global, Inc. (OTCPK MCTC) BREAKING NEWS Cannabis Global (MCTC) Begins Initial Distribution of Industry's First THC-V Beverages - Cannabis Global, Inc. (OTC PINK MCTC) (Cannabis Global or the Company), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, is excited to announce it has completed product development and has begun distribution of its unique tetrahydrocannabivarin (THC-V) coffee and tea products to product beta testers.
Pending full release of the products, the Company has implemented a 30-Day beta testing period, during which production for general release will continue.
Cannabis Global has integrated three internally developed technologies into the unique manufacturing process for the industry's first THC-V beverages. The first of these is the process developed by the Company to produce 70%+ loaded THC-V, controlled release, nanoparticles utilizing laboratory-based, pharmaceutical-grade production equipment. The Company is also utilizing both its internally developed powerization and one step dosing system, ensuring precise dosing and significantly faster production. The Company has filed provisional patents on all three technologies.
Our unique infusion and production technologies provide Cannabis Global with a product purity advantage as well as a clear path to low cost leadership, commented CEO Arman Tabatabaei. The THC-V cannabinoids are synthesized and entirely free of impurities. While there were some upfront technology development and intellectual property protection costs, we expect our ongoing variable production costs to be less than half of any potential competitor. Via our technologies, we turn one of the cannabis industry's most expensive items - pure THC-V cannabinoids - into a cost-effective solution that sets a new standard for product purity in the cannabinoid-based products marketplace.
The Company's first THC-V beverages are three blends of super-premium coffee packaged in compostable, single-serving coffee pods and several blends of organic green, black and pu'er teas, all packaged in single-serving formats.
Product and technology developments were a result of the Company's Project Varin, which was implemented last year to invent new manufacturing and infusion technologies for rare cannabinoids, such as THC-V. The Company plans to utilize the developed technologies in similar applications for other rare cannabinoids, with cannabigerol (CBG) being the likely next target for integration into the Company's beverage products.
✔️ CBD Infused Beverages Market Size Expected to Reach USD 2.8 Billion by 2025
💕 Found this article helpful? Spread the word and support us!